Results 31 to 40 of about 202,243 (244)

Synchronous Cystic Duct and Duodenal Neuroendocrine Tumours in a Patient with Neurofibromatosis 1: A Case Report [PDF]

Journal of Clinical and Diagnostic Research
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumour-predisposition syndrome associated with various tumours. Amongst gastrointestinal tumours, Gastrointestinal Stromal Tumours (GISTs) and periampullary Neuroendocrine Tumours (NET) are most ...
Vishaalpalaniswamy Ramaswamy, Angeline Mary Samy, Swaminathan Kalyanasundaram, Selvaraj Thangasamy   +3 more
doaj   +1 more source

Gastroenteropancreatic neuroendocrine tumours

The Lancet Oncology, 2008
Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms that present many clinical challenges. They secrete peptides and neuroamines that cause distinct clinical syndromes, including carcinoid syndrome. However, many are clinically silent until late presentation with mass effects.
Irvin M. Modlin, Kjell Oberg, Daniel C. Chung, Robert T. Jensen, Wouter W. De Herder, Rajesh V. Thakker, Martyn Caplin, DELLE FAVE, Gianfranco, Greg A. Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramon Salazar, Philippe Ruszniewski, Anders Sundin   +15 more
openaire   +5 more sources

Characterization of the neuroendocrine pancreatic tumors nature by MDCT enhancement pattern: a radio-pathological correlation [PDF]

, 2012
Introduction Pre-operative suspicion of neuroendocrine pancreatic lesions nature arises both from clinical (presence and the type of secreted hormone) and imaging findings.
NOVARIA, LISA
core   +1 more source

Efficacy and safety of radioligand therapy in a 76-year-old patient with metastatic grade 2 pancreatic neuroendocrine tumor

Endokrynologia Polska
Not required for Clinical Vignette.
Anna Zemczak, Olgierd Chrabański, Beata Kos-Kudła   +2 more
doaj   +1 more source

Pancreatic Neuroendocrine Tumours

Hong Kong Journal of Radiology, 2017
© 2017 Hong Kong College of Radiologists. Neuroendocrine tumours (NETs) are a heterogeneous group of malignancies that can arise in different organs. Although NETs account for only 0.5% of all malignancies, their incidence has significantly increased in recent years. In the Asia Pacific region, the most common site of primary NETs is the pancreas. Many
Au Yong, T. K., Lam, M. H.C., Cheng, H. C., Ngan, R. K.C., Cheuk, W.   +4 more
openaire   +3 more sources

Consensus Guidelines for High Grade Gastro-Entero Pancreatic (GEP) Neuroendocrine Tumours and Neuroendocrine Carcinomas (NEC). [PDF]

, 2016
Consensus Guidelines for High Grade Gastro-Entero Pancreatic (GEP) Neuroendocrine Tumours and Neuroendocrine Carcinomas (NEC)
Raymond, E, Caplin, M, Perren, A, Garcia-Carbonero, R, Ferone D, O'Toole, D, Anlauf, M, Niederle, B, Rindi, Guido, Baudin, E, Sedlackova, E, Toumpanakis, C, Sorbye, H, Wiedenmann, B, Cwikla, J B, Perren, Aurel   +15 more
core   +2 more sources

Cystic presentation of primary hepatic neuroendocrine tumour: a case report with a brief review of literature

Exploration of Targeted Anti-tumor Therapy, 2023
Neuroendocrine tumours (NETs) are a rare type of tumours that arise from the neuroendocrine cells which are distributed throughout the body. Of all the gastrointestinal tumours only 1–2% account for NETs.
Mangesh Londhe, Sakshi Garg, Sushama Gurwale, Charusheela Gore   +3 more
doaj   +1 more source

Thymic neuroendocrine tumours

, 2023
Thymic epithelial tumours include the subcategory of thymic neuroendocrine neoplasms, which comprise a spectrum of entities that mirrors their counterparts in the lung, i.e.
von der Thüsen, Jan; id_orcid, von der Thüsen, Jan   +1 more
core   +1 more source

Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours

BMJ Open Gastroenterology, 2021
Objective Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) encompass a diverse group of neoplasms that vary in their secretory products and in their location within the gastrointestinal tract.
Yuliang Chen, Tobias Else, Juanita L Merchant, Yana Zavros, David C Metz, Jayati T Chakrabarti, Karen Rico, Suzann Duan, Ritu L Pandey, Julie Starr, Bryson W Katona   +10 more
doaj   +1 more source

Management of neuroendocrine tumours

Annals of Oncology, 2004
This classification can be used for all types of NE tumour; not only for carcinoids. A classical midgut carcinoid will, in the new terminology, be classified as a well-differentiated endocrine carcinoma of the ileum, whereas a benign insulin-producing tumour of the pancreas will be a well-differentiated endocrine tumour of the pancreas.
openaire   +2 more sources